Armistice Capital reports 4.99% stake in Curis
Armistice Capital, LLC and Steven Boyd filed Amendment No. 3 to a Schedule 13G/A reporting beneficial ownership of 679,033 shares of Curis, Inc. common stock, representing 4.99% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Armistice Capital, LLC and Steven Boyd filed Amendment No. 3 to a Schedule 13G/A reporting beneficial ownership of 679,033 shares of Curis, Inc. common stock, representing 4.99% of the class. The filing states Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., which is the direct holder, and that voting and dispositive power are exercised jointly through the Investment Management Agreement. The filing is signed by Steven Boyd as managing member and is dated May 15, 2026.
Insights
Armistice reports a sub-5% passive stake via a managed fund.
Armistice Capital discloses beneficial ownership of 679,033 shares (4.99%), held directly by Armistice Capital Master Fund Ltd. and managed under an Investment Management Agreement. The filing classifies the position as ownership of 5 percent or less of the class.
The statement clarifies voting and dispositive power are exercised by Armistice Capital under the management agreement and that the Master Fund disclaims direct beneficial ownership attributable to its lack of voting/dispositive rights. Subsequent filings would show any material changes to percentage ownership.
The amendment is a routine Schedule 13G/A disclosure with joint-filing language.
The document includes a joint filing statement pursuant to Rule 13d-1(k), attributing responsibility for amendments to the Reporting Persons. It reiterates address, CUSIP 231269309, and the issuer's principal office address in Lexington, MA.
Because the position is reported at 4.99%, the filing aligns with passive/beneficial ownership disclosure conventions under Rule 13G; no change-of-control or activist intent is stated in this excerpt.
Key Figures
Key Terms
Schedule 13G/A regulatory
Investment Management Agreement financial
Beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Armistice Capital report in Curis (CRIS)?
Who is the reporting person on the Schedule 13G/A for CRIS?
Does the filing indicate Armistice is an active owner or passive investor?
How is beneficial ownership attributed between the Master Fund and Armistice?
AI-generated analysis. How Rhea-AI works. Not financial advice.